Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

NPT 2042

1 clinical trial

2 indications

Indication
Epilepsy
Indication
Alzheimer's disease
Clinical trial
A Single-center, Randomized, Placebo Controlled, Double-blind, Ascending Single-dose and Repeated-dose Trial to Determine the Safety and Pharmacokinetic Profile of NPT 2042 Soft-Gelatin Capsules Administered Orally to Healthy Adult Subjects
Status: Completed, Estimated PCD: 2023-03-17